Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Epsilon Healthcare Limited ( (AU:EPN) ) has issued an announcement.
Epsilon Healthcare Limited has experienced significant corporate turmoil, including disputes among directors, a decision to enter voluntary administration, and the cancellation of an Extraordinary General Meeting. Despite these challenges, the company’s operations have shown positive growth, particularly in manufacturing and clinical services, with record revenue reported at the Southport manufacturing facility and strong performance by Epsilon Clinics.
More about Epsilon Healthcare Limited
Epsilon Healthcare Limited operates in the healthcare industry, primarily focusing on manufacturing and clinical services. The company is engaged in the production of GMP manufactured medicinal cannabis products and provides telehealth services through Epsilon Clinics, formerly known as Tetra Health.
YTD Price Performance: 10.0%
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $4.48M
For an in-depth examination of EPN stock, go to TipRanks’ Stock Analysis page.
